| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 867374 | Biosensors and Bioelectronics | 2012 | 7 Pages |
In this report, a label-free reflectometric interference spectroscopy (RIfS) based microchip biosensor for the detection of circulating tumour cells (CTCs) is demonstrated. Highly ordered nanoporous anodic aluminium oxide (AAO) fabricated by electrochemical anodization of aluminium foil was used as the RIfS sensing platform. Biotinylated anti-EpCAM antibody that specifically binds to human cancer cells of epithelial origin such as pancreatic cancer cells (PANC-1) was covalently attached to the AAO surface through multiple surface functionalization steps. Whole blood or phosphate buffer saline spiked with low numbers of pancreatic cancer cells were successfully detected by specially designed microfluidic device incorporating an AAO RIfS sensor, without labour intensive fluorescence labelling and/or pre-enhancement process. Our results show that the developed device is capable of selectively detecting of cancer cells, within a concentrations range of 1000–100,000 cells/mL, with a detection limit of <1000 cells/mL, a response time of <5 min and sample volume of 50 μL of. The presented RIfS method shows considerable promise for translation to a rapid and cost-effective point-of-care diagnostic device for the detection of CTCs in patients with metastatic cancer.
► We develop a label-free reflectometric interference spectroscopy (RIfS) microchip biosensor for the detection of circulating tumour cells (CTCs) ► A nanoporous alumina functionlized with biotinylated human anti-EpCAM antibodies is used as a sensing platform ► The measurement of CTCs with concentrations of 1000–200,000 cells/mL in buffer and whole blood is demonstrated. ► The device is highly selective to CTCs, has response time of <5 min and requires less than 50 μL of sample.
